Astec Lifesciences shines on reporting around 5 fold jump in Q4 consolidated net profit

03 May 2018 Evaluate

Astec Lifesciences is currently trading at Rs. 731.00, up by 40.05 points or 5.80% from its previous closing of Rs. 690.95 on the BSE.

The scrip opened at Rs. 723.10 and has touched a high and low of Rs. 770.00 and Rs. 710.75 respectively. So far 66443 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 770.00 on 03-May-2018 and a 52 week low of Rs. 475.00 on 31-Oct-2017.

Last one week high and low of the scrip stood at Rs. 770.00 and Rs. 672.00 respectively. The current market cap of the company is Rs. 1436.37 crore.

The promoters holding in the company stood at 67.31%, while Institutions and Non-Institutions held 2.95% and 29.74% respectively.

Astec Lifesciences has reported around 5 fold jump in its net profit at Rs 17.10 crore for the quarter ended March 31, 2018 as compared to Rs 3.49 crore for the same quarter in the previous year. Total income of the company has increased by 42.56% at Rs 130.14 crore for quarter under review as compared to Rs 91.29 crore for the quarter ended March 31, 2017.

On consolidated basis, the company has reported around 5 fold jump in its net profit at Rs 17.16 crore for the quarter ended March 31, 2018 as compared to Rs 3.46 crore for the corresponding quarter in the FY17. Total consolidated income of the company rose 42.48% at Rs 130.14 crore for quarter under review as compared to Rs 91.34 crore for the same quarter ended previous year.

For the year ended March 31, 2018, the company has posted a rise of 83.18% in its net profit at Rs 34.97 crore as compared to Rs 19.09 crore for the same period in the previous year. Total income of the company increased 20.07% at Rs 378.95 crore for year under review as compared to Rs 315.60 crore for the period ended March 31, 2017.

For the year ended March 31, 2018, on the consolidated basis, the company has posted a rise of 82.53% in its net profit at Rs 34.90 crore as compared to Rs 19.12 crore for the same period in the previous year. Total income of the company has increased by 19.82% at Rs 378.95 crore for year under review as compared to Rs 316.27 crore for the period ended March 31, 2017.

Astec Lifesciences Share Price

704.00 0.00 (0.00%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
UPL 770.00
PI Industries 3235.20
Bayer CropScience 4535.00
Sharda Cropchem 840.55
Sumitomo Chemical 464.40
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×